Indaptus Therapeutics, Inc. Common Stock
Symbol: INDP (NASDAQ)
3.71
▲ (6.00%) 0.210
Company Description:
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
Key Stats
- Today's Open: $3.43
- Today's High: $4.473
- Today's Low: $3.285
- Today's Volume: 922.33K
- Yesterday Close: $3.5
- Yesterday High: $3.6798
- Yesterday Low: $2.88
- Yesterday Volume: 443.58K
- Last Min Volume: 100
- Last Min High: $3.71
- Last Min Low: $3.71
- Last Min VWAP: $3.71
Company Profile
- Name: Indaptus Therapeutics, Inc. Common Stock
- Website: https://www.indaptusrx.com
- Listed Date: 2021-08-04
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001857044
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.87M
- Round Lot: 100
- Outstanding Shares: 1.11M
- Asset Type: CS
RECENT FILINGS FOR INDP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 8-K | View |
| 2025-09-03 | S-1/A | View |
| 2025-09-02 | S-1 | View |
| 2025-09-02 | 424B5 | View |
| 2025-08-20 | EFFECT | View |
| 2025-08-20 | EFFECT | View |
| 2025-08-19 | CORRESP | View |
| 2025-08-19 | CORRESP | View |
| 2025-08-18 | UPLOAD | View |
| 2025-08-18 | UPLOAD | View |
| 2025-08-13 | S-3 | View |
| 2025-08-13 | S-3 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 8-K | View |
| 2025-07-16 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-26 | 8-K | View |
| 2025-06-23 | DEF 14A | View |
Latest News on INDP